GenRx Midazolam midazolam 5mg/5mL solution for injection ampoule

Active ingredient:

midazolam, Quantity: 5 mg

Available from:

Arrotex Pharmaceuticals Pty Ltd

INN (International Name):

Midazolam

Pharmaceutical form:

Injection, solution

Composition:

Excipient Ingredients: hydrochloric acid; water for injections; sodium hydroxide; sodium chloride

Administration route:

Intravenous, Intramuscular

Units in package:

5 ampoules

Prescription type:

(S4) Prescription Only Medicine

Therapeutic indications:

IV as an agent for conscious sedation prior to short surgical, diagnostic, therapeutic or endoscopic procedures, such as bronchoscopy, gastroscopy, cystoscopy, coronary angiography and cardiac catheterisation, either alone or in conjunction with a narcotic. IV for induction of anaesthesia, preliminary to administration of other anaesthetic agents. With the use of a narcotic premedicant, induction of anaesthesia can be attained with a narrower dose range and in a shorter period of time. IV for sedation in intensive care units; intermittent administration or continuous infusion. IM for preoperative sedation (induction of sleepiness or drowsiness and relief of apprehension) and to impair memory of perioperative events.

Product summary:

Visual Identification: A clear colourless to pale yellow solution.; Container Type: Ampoule; Container Material: Glass Type I Clear; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius

Authorization status:

Licence status A

Authorization date:

2014-10-30